Herbs (Global Traditional) · Southeast Asian
Daun Ungu (Graptophyllum pictum) (Graptophyllum pictum)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Daun Ungu (Graptophyllum pictum) contains flavonoids and phenolic compounds that reduce inflammatory cytokines IL-6 and TNF-α through inhibition of NF-κB pathway activation. This Indonesian medicinal plant demonstrates preliminary anti-inflammatory and endometriosis-relieving effects in animal studies.
Daun Ungu (Graptophyllum pictum) is a perennial shrub in the Acanthaceae family native to Southeast Asia, particularly Indonesia, where it's known by its Javanese traditional name meaning 'purple leaves.' The medicinal leaves are typically prepared through aqueous decoction or extracted using methanol, ethanol, or advanced methods like microwave-assisted and ultrasonic-assisted extraction.
Current evidence is limited to preclinical animal and in vitro studies, with no human clinical trials, RCTs, or meta-analyses identified. The most comprehensive study involved 90 rats with induced endometriosis, where aqueous and methanolic extracts at 50-275 mg/kg showed effects comparable to letrozole and aspirin. No PMIDs were provided in the research dossier.
Animal studies used oral doses of 50-275 mg/kg body weight daily of aqueous or methanolic leaf extracts. In vitro studies utilized 100 µg/mL methanolic extract concentrations. No human dosage data is available, and extracts are not standardized for active compound content. Consult a healthcare provider before starting any new supplement.
Daun Ungu (Graptophyllum pictum) leaves contain bioactive compounds as primary constituents rather than significant macronutrient content. Proximate analysis indicates moderate moisture content (~70-80% in fresh leaves), with dried leaf powder containing approximately 10-15% crude protein, 3-5% crude fat, 15-20% crude fiber, and 40-50% carbohydrates (approximate values from limited studies). Key micronutrients include calcium (~1.2-1.8 g/100g dry weight), potassium (~2.0-2.5 g/100g dry weight), and iron (~15-25 mg/100g dry weight), though precise values vary by cultivar and soil conditions. Bioactive compounds are the most studied fraction: alkaloids (including graptophylline and non-protein amino acid derivatives), flavonoids (~2-4% dry weight, including quercetin, kaempferol, and rutin glycosides), tannins (~1-3% dry weight), saponins, and anthraquinone glycosides. Chlorogenic acid and caffeic acid derivatives contribute to the phenolic pool, with total phenolic content estimated at 20-50 mg GAE/g dry extract depending on solvent system. Anthocyanins (responsible for purple pigmentation in some varieties) include cyanidin-3-glucoside. Carotenoids including beta-carotene are present at low concentrations (~0.5-1.2 mg/100g fresh weight). Bioavailability data is limited; flavonoid glycosides require gut microbial hydrolysis for aglycone absorption, and alkaloid bioavailability has not been formally characterized in human studies. Ethanol and water extracts show higher phenolic yield than non-polar solvents.
Daun Ungu's flavonoids and phenolic compounds suppress the nuclear factor-κB (NF-κB) signaling pathway, preventing transcription of pro-inflammatory genes. This leads to decreased production of inflammatory cytokines including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). The compounds also appear to modulate estrogen metabolism and reduce oxidative stress in reproductive tissues.
Current evidence comes primarily from animal studies, with no published human clinical trials available. Rat studies on endometriosis showed reduced endometrial implant size and improved folliculogenesis at doses of 50-275 mg/kg body weight over 14-28 day periods. Anti-inflammatory effects were demonstrated in mouse models with significant reductions in IL-6 and TNF-α levels. Human clinical data is needed to confirm efficacy and establish safe dosing protocols.
Safety data in humans is limited due to lack of clinical trials. Traditional use suggests general tolerability, but standardized safety profiles have not been established. Potential interactions with anti-inflammatory medications and hormone therapies are theoretically possible due to the plant's bioactive mechanisms. Pregnant and breastfeeding women should avoid use due to insufficient safety data and potential hormonal effects.
